AB Sciex, U. of Wollongong Partner on Lipidomics Research | GenomeWeb

NEW YORK (GenomeWeb News) – AB Sciex and the University of Wollongong in Australia today announced a research partnership aimed at developing lipid analysis capabilities.

The deal provides AB Sciex, a Danaher company, with an exclusive license to the university's ozone-induced dissociation, or OzID, intellectual property, a technology that allows for a better understanding of lipid structure more quickly and in greater detail than is possible with other technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.